Prio Wealth Limited Partnership lifted its position in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 53.0% during the second quarter, HoldingsChannel.com reports. The fund owned 380,112 shares of the medical instruments supplier’s stock after purchasing an additional 131,616 shares during the period. Prio Wealth Limited Partnership’s holdings in DENTSPLY SIRONA were worth $16,637,000 at the end of the most recent quarter.
Other large investors have also recently made changes to their positions in the company. Piedmont Investment Advisors LLC acquired a new stake in shares of DENTSPLY SIRONA in the 2nd quarter valued at approximately $117,000. Jane Street Group LLC acquired a new stake in shares of DENTSPLY SIRONA in the 4th quarter valued at approximately $313,000. IBM Retirement Fund raised its position in shares of DENTSPLY SIRONA by 49.1% in the 1st quarter. IBM Retirement Fund now owns 4,955 shares of the medical instruments supplier’s stock valued at $249,000 after acquiring an additional 1,631 shares during the period. NuWave Investment Management LLC raised its position in shares of DENTSPLY SIRONA by 184.6% in the 1st quarter. NuWave Investment Management LLC now owns 5,237 shares of the medical instruments supplier’s stock valued at $263,000 after acquiring an additional 3,397 shares during the period. Finally, Northwest Investment Counselors LLC raised its position in shares of DENTSPLY SIRONA by 21.0% in the 2nd quarter. Northwest Investment Counselors LLC now owns 7,582 shares of the medical instruments supplier’s stock valued at $332,000 after acquiring an additional 1,318 shares during the period. Institutional investors and hedge funds own 94.10% of the company’s stock.
A number of analysts recently weighed in on the stock. Barrington Research downgraded shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday. Barclays dropped their target price on shares of DENTSPLY SIRONA from $55.00 to $41.00 and set an “equal weight” rating on the stock in a report on Wednesday. Jefferies Financial Group dropped their target price on shares of DENTSPLY SIRONA from $58.00 to $46.00 and set a “buy” rating on the stock in a report on Wednesday. Stifel Nicolaus dropped their target price on shares of DENTSPLY SIRONA from $57.00 to $46.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, HC Wainwright restated a “hold” rating and set a $40.00 target price on shares of DENTSPLY SIRONA in a report on Wednesday. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and five have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $52.18.
In other news, Director Michael J. Coleman sold 6,038 shares of the firm’s stock in a transaction that occurred on Friday, June 1st. The shares were sold at an average price of $43.97, for a total transaction of $265,490.86. Following the completion of the transaction, the director now directly owns 26,960 shares of the company’s stock, valued at approximately $1,185,431.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Michael C. Alfano sold 1,404 shares of the firm’s stock in a transaction that occurred on Wednesday, May 30th. The stock was sold at an average price of $45.83, for a total transaction of $64,345.32. Following the transaction, the director now directly owns 13,458 shares of the company’s stock, valued at $616,780.14. The disclosure for this sale can be found here. 1.93% of the stock is owned by company insiders.
Shares of XRAY stock opened at $39.02 on Friday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.46 and a current ratio of 1.69. The company has a market cap of $8.92 billion, a price-to-earnings ratio of 15.61, a P/E/G ratio of 2.57 and a beta of 1.27. DENTSPLY SIRONA Inc has a 52 week low of $38.80 and a 52 week high of $68.98.
DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Tuesday, August 7th. The medical instruments supplier reported $0.60 EPS for the quarter, topping the consensus estimate of $0.59 by $0.01. The firm had revenue of $1.04 billion for the quarter, compared to the consensus estimate of $1.03 billion. DENTSPLY SIRONA had a negative net margin of 39.62% and a positive return on equity of 9.12%. During the same period last year, the company posted $0.65 EPS. analysts forecast that DENTSPLY SIRONA Inc will post 2.07 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 12th. Stockholders of record on Friday, September 28th will be paid a dividend of $0.0875 per share. The ex-dividend date of this dividend is Thursday, September 27th. This represents a $0.35 annualized dividend and a dividend yield of 0.90%. DENTSPLY SIRONA’s dividend payout ratio is currently 13.16%.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Featured Story: Book Value Per Share – BVPS
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.